|
1
|
Varone F, Friello L, Di Blasi C, Sgalla G,
Luigetti M, Iovene B, Richeldi L, Della Marca G and Brunetti V:
Restless legs syndrome: A new comorbidity in idiopathic pulmonary
fibrosis. Respir Med. 170(105982)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tachibana N: Living with restless legs
syndrome/willis-ekbom disease. Sleep Med Clin. 10:359–367, xv.
2015.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cotter PE and O'Keeffe ST: Restless leg
syndrome: Is it a real problem? Ther Clin Risk Manag. 2:465–475.
2006.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Allen RP, Picchietti DL, Auerbach M, Cho
YW, Connor JR, Earley CJ, Garcia-Borreguero D, Kotagal S, Manconi
M, Ondo W, et al: Evidence-based and consensus clinical practice
guidelines for the iron treatment of restless legs
syndrome/Willis-Ekbom disease in adults and children: An IRLSSG
task force report. Sleep Med. 41:27–44. 2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Buchfuhrer MJ: Strategies for the
treatment of restless legs syndrome. Neurotherapeutics. 9:776–790.
2012.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Allen RP: Restless leg
syndrome/willis-ekbom disease pathophysiology. Sleep Med Clin.
10:207–214, xi. 2015.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Schormair B, Kemlink D, Roeske D, Eckstein
G, Xiong L, Lichtner P, Ripke S, Trenkwalder C, Zimprich A,
Stiasny-Kolster K, et al: PTPRD (protein tyrosine phosphatase
receptor type delta) is associated with restless legs syndrome. Nat
Genet. 40:946–948. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Winkelmann J, Czamara D, Schormair B,
Knauf F, Schulte EC, Trenkwalder C, Dauvilliers Y, Polo O, Högl B,
Berger K, et al: Genome-wide association study identifies novel
restless legs syndrome susceptibility loci on 2p14 and 16q12.1.
PLoS Genet. 7(e1002171)2011.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Winkelmann J, Schormair B, Lichtner P,
Ripke S, Xiong L, Jalilzadeh S, Fulda S, Pütz B, Eckstein G, Hauk
S, et al: Genome-wide association study of restless legs syndrome
identifies common variants in three genomic regions. Nat Genet.
39:1000–1006. 2007.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Moore H IV, Winkelmann J, Lin L, Finn L,
Peppard P and Mignot E: Periodic leg movements during sleep are
associated with polymorphisms in BTBD9, TOX3/BC034767, MEIS1,
MAP2K5/SKOR1, and PTPRD. Sleep. 37:1535–1542. 2014.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Stefansson H, Rye DB, Hicks A, Petursson
H, Ingason A, Thorgeirsson TE, Palsson S, Sigmundsson T, Sigurdsson
AP, Eiriksdottir I, et al: A genetic risk factor for periodic limb
movements in sleep. N Engl J Med. 357:639–647. 2007.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Vilariño-Güell C, Soto AI, Young JE, Lin
SC, Uitti RJ, Wszolek ZK and Farrer MJ: Susceptibility genes for
restless legs syndrome are not associated with Parkinson disease.
Neurology. 71:222–223. 2008.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Allen RP, Auerbach S, Bahrain H, Auerbach
M and Earley CJ: The prevalence and impact of restless legs
syndrome on patients with iron deficiency anemia. Am J Hematol.
88:261–264. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Earley CJ, Connor JR, Beard JL, Malecki
EA, Epstein DK and Allen RP: Abnormalities in CSF concentrations of
ferritin and transferrin in restless legs syndrome. Neurology.
54:1698–1700. 2000.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Mizuno S, Mihara T, Miyaoka T, Inagaki T
and Horiguchi J: CSF iron, ferritin and transferrin levels in
restless legs syndrome. J Sleep Res. 14:43–47. 2005.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rizzo G, Manners D, Testa C, Tonon C,
Vetrugno R, Marconi S, Plazzi G, Pizza F, Provini F, Malucelli E,
et al: Low brain iron content in idiopathic restless legs syndrome
patients detected by phase imaging. Mov Disord. 28:1886–1890.
2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Patton SM, Ponnuru P, Snyder AM, Podskalny
GD and Connor JR: Hypoxia-inducible factor pathway activation in
restless legs syndrome patients. Eur J Neurol. 18:1329–1335.
2011.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Benediktsdottir B, Janson C, Lindberg E,
Arnardóttir ES, Olafsson I, Cook E, Thorarinsdottir EH and Gislason
T: Prevalence of restless legs syndrome among adults in Iceland and
Sweden: Lung function, comorbidity, ferritin, biomarkers and
quality of life. Sleep Med. 11:1043–1048. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Connor JR, Ponnuru P, Lee BY, Podskalny
GD, Alam S, Allen RP, Earley CJ and Yang QX: Postmortem and imaging
based analyses reveal CNS decreased myelination in restless legs
syndrome. Sleep Med. 12:614–619. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Allen RP, Connor JR, Hyland K and Earley
CJ: Abnormally increased CSF 3-Ortho-methyldopa (3-OMD) in
untreated restless legs syndrome (RLS) patients indicates more
severe disease and possibly abnormally increased dopamine
synthesis. Sleep Med. 10:123–128. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Stiasny-Kolster K, Möller JC, Zschocke J,
Bandmann O, Cassel W, Oertel WH and Hoffmann GF: Normal
dopaminergic and serotonergic metabolites in cerebrospinal fluid
and blood of restless legs syndrome patients. Mov Disord.
19:192–196. 2004.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Erikson KM, Jones BC, Hess EJ, Zhang Q and
Beard JL: Iron deficiency decreases dopamine D1 and D2 receptors in
rat brain. Pharmacol Biochem Behav. 69:409–418. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Erikson KM, Jones BC and Beard JL: Iron
deficiency alters dopamine transporter functioning in rat striatum.
J Nutr. 130:2831–2837. 2000.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Trifu SC, Tudor A and Radulescu I:
Aggressive behavior in psychiatric patients in relation to hormonal
imbalance (Review). Exp Ther Med. 20:3483–3487. 2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Oertel W, Trenkwalder C, Beneš H,
Ferini-Strambi L, Högl B, Poewe W, Stiasny-Kolster K, Fichtner A,
Schollmayer E, Kohnen R, et al: Long-term safety and efficacy of
rotigotine transdermal patch for moderate-to-severe idiopathic
restless legs syndrome: A 5-year open-label extension study. Lancet
Neurol. 10:710–720. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Desautels A, Turecki G, Montplaisir J,
Xiong L, Walters AS, Ehrenberg BL, Brisebois K, Desautels AK,
Gingras Y, Johnson WG, et al: Restless legs syndrome: confirmation
of linkage to chromosome 12q, genetic heterogeneity, and evidence
of complexity. Arch Neurol. 62:591–596. 2005.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Yang Q, Li L, Chen Q, Foldvary-Schaefer N,
Ondo WG and Wang QK: Association studies of variants in MEIS1,
BTBD9, and MAP2K5/SKOR1 with restless legs syndrome in a US
population. Sleep Med. 12:800–804. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Ekbom K and Ulfberg J: Restless legs
syndrome. J Intern Med. 266:419–431. 2009.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Bassetti CL, Mauerhofer D, Gugger M,
Mathis J and Hess CW: Restless legs syndrome: A clinical study of
55 patients. Eur Neurol. 45:67–74. 2001.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Winkelmann J, Wetter TC, Collado-Seidel V,
Gasser T, Dichgans M, Yassouridis A and Trenkwalder C: Clinical
characteristics and frequency of the hereditary restless legs
syndrome in a population of 300 patients. Sleep. 23:597–602.
2000.PubMed/NCBI
|
|
31
|
Holmes R, Tluk S, Metta V, Patel P, Rao R,
Williams A and Chaudhuri KR: Nature and variants of idiopathic
restless legs syndrome: observations from 152 patients referred to
secondary care in the UK. J Neural Transm (Vienna). 114:929–934.
2007.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Michaud M, Chabli A, Lavigne G and
Montplaisir J: Arm restlessness in patients with restless legs
syndrome. Mov Disord. 15:289–293. 2000.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Karroum EG, Leu-Semenescu S and Arnulf I:
Topography of the sensations in primary restless legs syndrome. J
Neurol Sci. 320:26–31. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Buchfuhrer MJ: Restless legs syndrome
(RLS) with expansion of symptoms to the face. Sleep Med. 9:188–190.
2008.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ruppert E, Cretin B, Meyer C, Kilic-Huck U
and Bourgin P: Characterization of periodic upper limb movement
disorder in a patient with restless arms syndrome. Mov Disord.
27:1459–1461. 2012.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Horvath J, Landis T and Burkhard PR:
Restless arms. Lancet. 371(530)2008.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Michaud M, Lavigne G, Desautels A, Poirier
G and Montplaisir J: Effects of immobility on sensory and motor
symptoms of restless legs syndrome. Mov Disord. 17:112–115.
2002.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Duffy JF, Lowe AS, Silva EJ and Winkelman
JW: Periodic limb movements in sleep exhibit a circadian rhythm
that is maximal in the late evening/early night. Sleep Med.
12:83–88. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hening WA, Walters AS, Wagner M, Rosen R,
Chen V, Kim S, Shah M and Thai O: Circadian rhythm of motor
restlessness and sensory symptoms in the idiopathic restless legs
syndrome. Sleep. 22:901–912. 1999.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Trenkwalder C, Winkelmann J, Inoue Y and
Paulus W: Restless legs syndrome-current therapies and management
of augmentation. Nat Rev Neurol. 11:434–445. 2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Trenkwalder C, Hening WA, Walters AS,
Campbell SS, Rahman K and Chokroverty S: Circadian rhythm of
periodic limb movements and sensory symptoms of restless legs
syndrome. Mov Disord. 14:102–110. 1999.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Möller C, Wetter TC, Köster J and
Stiasny-Kolster K: Differential diagnosis of unpleasant sensations
in the legs: Prevalence of restless legs syndrome in a primary care
population. Sleep Med. 11:161–166. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hening WA, Allen RP, Washburn M, Lesage S
and Earley CJ: Validation of the Hopkins telephone diagnostic
interview for restless legs syndrome. Sleep Med. 9:283–289.
2008.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Benes H and Kohnen R: Validation of an
algorithm for the diagnosis of restless legs syndrome: The restless
legs syndrome-diagnostic index (RLS-DI). Sleep Med. 10:515–523.
2009.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Hening WA, Allen RP, Washburn M, Lesage SR
and Earley CJ: The four diagnostic criteria for restless legs
syndrome are unable to exclude confounding conditions (‘mimics’).
Sleep Med. 10:976–981. 2009.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Trifu S, Carp EG and Nadoleanu A: Alcohol
as a substitute, mask of depression and ‘antidote’ of narcissism.
Eur Proc Soc Behav Sci. 31:986–994. 2017.
|
|
47
|
Richeldi L, Collard HR and Jones MG:
Idiopathic pulmonary fibrosis. Lancet. 389:1941–1952.
2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Raghu G, Amatto VC, Behr J and Stowasser
S: Comorbidities in idiopathic pulmonary fibrosis patients: A
systematic literature review. Eur Respir J. 46:1113–1130.
2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mucsi I, Molnar MZ, Ambrus C, Szeifert L,
Kovacs AZ, Zoller R, Barótfi S, Remport A and Novak M: Restless
legs syndrome, insomnia and quality of life in patients on
maintenance dialysis. Nephrol Dial Transplant. 20:571–577.
2005.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Tuncel D, Orhan FO, Sayarlioglu H, Isık
IO, Utku U and Dinc A: Restless legs syndrome in hemodialysis
patients: Association with depression and quality of life. Sleep
Breath. 15:311–315. 2011.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Takaki J, Nishi T, Nangaku M, Shimoyama H,
Inada T, Matsuyama N, Kumano H and Kuboki T: Clinical and
psychological aspects of restless legs syndrome in uremic patients
on hemodialysis. Am J Kidney Dis. 41:833–839. 2003.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Ohayon MM, O'Hara R and Vitiello MV:
Epidemiology of restless legs syndrome: A synthesis of the
literature. Sleep Med Rev. 16:283–295. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Stefanidis I, Vainas A, Dardiotis E,
Giannaki CD, Gourli P, Papadopoulou D, Vakianis P, Patsidis E,
Eleftheriadis T, Liakopoulos V, et al: Restless legs syndrome in
hemodialysis patients: An epidemiologic survey in Greece. Sleep
Med. 14:1381–1386. 2013.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Turk AC, Ozkurt S, Turgal E and Sahin F:
The association between the prevalence of restless leg syndrome,
fatigue, and sleep quality in patients undergoing hemodialysis.
Saudi Med J. 39:792–798. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Zadeh Saraji N, Hami M, Boostani R and
Mojahedi MJ: Restless leg syndrome in chronic hemodialysis patients
in Mashhad hemodialysis centers. J Renal Inj Prev. 6:137–141.
2016.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Azar SA, Hatefi R and Talebi M: Evaluation
of effect of renal transplantation in treatment of restless legs
syndrome. Transplant Proc. 39:1132–1133. 2007.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Pizza F, Persici E, La Manna G, Campieri
C, Plazzi G, Carretta E, Cappuccilli ML, Ferri B, Stefoni S and
Montagna P: Family recurrence and oligo-anuria predict uremic
restless legs syndrome. Acta Neurol Scand. 125:403–409.
2012.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Micozkadioglu H, Ozdemir FN, Kut A, Sezer
S, Saatci U and Haberal M: Gabapentin versus levodopa for the
treatment of restless legs syndrome in hemodialysis patients: An
open-label study. Ren Fail. 26:393–397. 2004.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Razazian N, Azimi H, Heidarnejadian J,
Afshari D and Ghadami MR: Gabapentin versus levodopa-c for the
treatment of restless legs syndrome in hemodialysis patients: A
randomized clinical trial. Saudi J Kidney Dis Transpl. 26:271–278.
2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Sagheb MM, Dormanesh B, Fallahzadeh MK,
Akbari H, Sohrabi Nazari S, Heydari ST and Behzadi S: Efficacy of
vitamins C, E, and their combination for treatment of restless legs
syndrome in hemodialysis patients: A randomized, double-blind,
placebo-controlled trial. Sleep Med. 13:542–545. 2012.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Cikrikcioglu MA, Hursitoglu M, Erkal H,
Kınas BE, Sztajzel J, Cakirca M, Arslan AG, Erek A, Halac G and
Tukek T: Oxidative stress and autonomic nervous system functions in
restless legs syndrome. Eur J Clin Invest. 41:734–742.
2011.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Giannaki CD, Hadjigeorgiou GM, Karatzaferi
C, Maridaki MD, Koutedakis Y, Founta P, Tsianas N, Stefanidis I and
Sakkas GK: A single-blind randomized controlled trial to evaluate
the effect of 6 months of progressive aerobic exercise training in
patients with uraemic restless legs syndrome. Nephrol Dial
Transplant. 28:2834–2840. 2013.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Saha L: Irritable bowel syndrome:
Pathogenesis, diagnosis, treatment, and evidence-based medicine.
World J Gastroenterol. 20:6759–6773. 2014.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Wajszilber D, Santiseban JA and Gruber R:
Sleep disorders in patients with ADHD: Impact and management
challenges. Nat Sci Sleep. 10:453–480. 2018.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Thomas R, Sanders S, Doust J, Beller E and
Glasziou P: Prevalence of attention-deficit/hyperactivity disorder:
A systematic review and meta-analysis. Pediatrics. 135:e994–e1001.
2015.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Chervin RD, Archbold KH, Dillon JE, Pituch
KJ, Panahi P, Dahl RE and Guilleminault C: Associations between
symptoms of inattention, hyperactivity, restless legs, and periodic
leg movements. Sleep. 25:213–218. 2002.PubMed/NCBI
|
|
67
|
Chaiard J and Weaver TE: Update on
research and practices in major sleep disorders: Part II-Insomnia,
Willis-Ekbom disease (Restless Leg Syndrome), and narcolepsy. J
Nurs Scholarsh. 51:624–633. 2019.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Didato G, Di Giacomo R, Rosa GJ, Dominese
A, de Curtis M and Lanteri P: Restless legs syndrome across the
lifespan: Symptoms, pathophysiology, management and daily life
impact of the different patterns of disease presentation. Int J
Environ Res Public Health. 17(3658)2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Anguelova GV, Vlak MHM, Kurvers AGY and
Rijsman RM: Pharmacologic and nonpharmacologic treatment of
restless legs Syndrome. Sleep Med Clin. 13:219–230. 2018.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Garcia-Borreguero D, Silber MH, Winkelman
JW, Högl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y,
Manconi M, Oertel W, et al: Guidelines for the first-line treatment
of restless legs syndrome/Willis-Ekbom disease, prevention and
treatment of dopaminergic augmentation: A combined task force of
the IRLSSG, EURLSSG, and the RLS-foundation. Sleep Med. 21:1–11.
2016.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Trenkwalder C, Winkelmann J, Oertel W,
Virgin G, Roubert B and Mezzacasa A: FCM-RLS Study Investigators.
Ferric carboxymaltose in patients with restless legs syndrome and
nonanemic iron deficiency: A randomized trial. Mov Disord.
32:1478–1482. 2017.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Trenkwalder C, Allen R, Högl B, Clemens S,
Patton S, Schormair B and Winkelmann J: Comorbidities, treatment,
and pathophysiology in restless legs syndrome. Lancet Neurol.
17:994–1005. 2018.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Avni T, Reich S, Lev N and Gafter-Gvili A:
Iron supplementation for restless legs syndrome-A systematic review
and meta-analysis. Eur J Intern Med. 63:34–41. 2019.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Akpinar S: Treatment of restless legs
syndrome with levodopa plus benserazide. Arch Neurol.
39(739)1982.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Benes H, Kurella B, Kummer J, Kazenwadel
J, Selzer R and Kohnen R: Rapid onset of action of levodopa in
restless legs syndrome: A double-blind, randomized, multicenter,
crossover trial. Sleep. 22:1073–1081. 1999.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Trenkwalder C, Garcia-Borreguero D,
Montagna P, Lainey E, de Weerd AW, Tidswell P, Saletu-Zyhlarz G,
Telstad W and Ferini-Strambi L: Therapy with Ropiunirole; Efficacy
and Tolerability in RLS 1 Study Group. Efficacy and Tolerability in
RLS 1 Study Group. Ropinirole in the treatment of restless legs
syndrome: Results from the TREAT RLS 1 study, a 12 week,
randomised, placebo controlled study in 10 European countries. J
Neurol Neurosurg Psychiatry. 75:92–97. 2004.PubMed/NCBI
|
|
77
|
Collado-Seidel V, Kazenwadel J, Wetter TC,
Kohnen R, Winkelmann J, Selzer R, Oertel WH and Trenkwalder C: A
controlled study of additional sr-L-dopa in L-dopa-responsive
restless legs syndrome with late-night symptoms. Neurology.
52:285–290. 1999.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Allen RP and Earley CJ: Augmentation of
the restless legs syndrome with carbidopa/levodopa. Sleep.
19:205–213. 1996.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Wijemanne S and Ondo W: Restless Legs
Syndrome: Clinical features, diagnosis and a practical approach to
management. Pract Neurol. 17:444–452. 2017.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Picchietti DL, Hensley JG, Bainbridge JL,
Lee KA, Manconi M, McGregor JA, Silver RM, Trenkwalder C and
Walters AS: International Restless Legs Syndrome Study Group
(IRLSSG). Consensus clinical practice guidelines for the diagnosis
and treatment of restless legs syndrome/Willis-Ekbom disease during
pregnancy and lactation. Sleep Med Rev. 22:64–77. 2015.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Beneš H, García-Borreguero D,
Ferini-Strambi L, Schollmayer E, Fichtner A and Kohnen R:
Augmentation in the treatment of restless legs syndrome with
transdermal rotigotine. Sleep Med. 13:589–597. 2012.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Garcia-Borreguero D, Cano-Pumarega I and
Marulanda R: Management of treatment failure in restless legs
syndrome (Willis-Ekbom disease). Sleep Med Rev. 41:50–60.
2018.PubMed/NCBI View Article : Google Scholar
|
|
83
|
Comella CL: Treatment of restless legs
syndrome. Neurotherapeutics. 11:177–187. 2014.PubMed/NCBI View Article : Google Scholar
|
|
84
|
Prosperetti C and Manconi M: Restless legs
syndrome/willis-ekbom disease and pregnancy. Sleep Med Clin.
10:323–329, xiv. 2015.PubMed/NCBI View Article : Google Scholar
|
|
85
|
Telstad W, Sørensen O, Larsen S, Lillevold
PE, Stensrud P and Nyberg-Hansen R: Treatment of the restless legs
syndrome with carbamazepine: A double blind study. Br Med J (Clin
Res Ed). 288:444–446. 1984.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Garcia-Borreguero D, Larrosa O, de la
Llave Y, Verger K, Masramon X and Hernandez G: Treatment of
restless legs syndrome with gabapentin: A double-blind, cross-over
study. Neurology. 59:1573–1579. 2002.PubMed/NCBI View Article : Google Scholar
|
|
87
|
Jiménez-Jiménez FJ, Alonso-Navarro H,
García-Martín E and Agúndez JAG: Treatment options for idiopathic
restless legs Syndrome. Eur Neurol Rev. 10:45–55. 2015.
|
|
88
|
Walters AS, Wagner ML, Hening WA, Grasing
K, Mills R, Chokroverty S and Kavey N: Successful treatment of the
idiopathic restless legs syndrome in a randomized double-blind
trial of oxycodone versus placebo. Sleep. 16:327–332.
1993.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Walters AS, Winkelmann J, Trenkwalder C,
Fry JM, Kataria V, Wagner M, Sharma R, Hening W and Li L: Long-term
follow-up on restless legs syndrome patients treated with opioids.
Mov Disord. 16:1105–1109. 2001.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Montagna P, Sassoli de Bianchi L, Zucconi
M, Cirignotta F and Lugaresi E: Clonazepam and vibration in
restless legs syndrome. Acta Neurol Scand. 69:428–430.
1984.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Saletu M, Anderer P, Saletu-Zyhlarz G,
Prause W, Semler B, Zoghlami A, Gruber G, Hauer C and Saletu B:
Restless legs syndrome (RLS) and periodic limb movement disorder
(PLMD): Acute placebo-controlled sleep laboratory studies with
clonazepam. Eur Neuropsychopharmacol. 11:153–161. 2001.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Xu XM, Liu Y, Jia SY, Dong MX, Cao D and
Wei YD: Complementary and alternative therapies for restless legs
syndrome: An evidence-based systematic review. Sleep Med Rev.
38:158–167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Einollahi B and Izadianmehr N: Restless
leg syndrome: A neglected diagnosis. Nephrourol Mon.
6(e22009)2014.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Harrison EG, Keating JL and Morgan PE:
Non-pharmacological interventions for restless legs syndrome: A
systematic review of randomised controlled trials. Disabil Rehabil.
41:2006–2014. 2019.PubMed/NCBI View Article : Google Scholar
|
